Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Behring Diagnostics was a leading global provider of in vitro diagnostic products, specializing in protein analysis, immunology, and clinical chemistry. Originally a division of the German conglomerate Hoechst AG, the company was renowned for its nephelometry systems and plasma protein assays. In 1997, it merged with Dade International to form Dade Behring, which was subsequently acquired by Siemens in 2007 for approximately $7 billion. The company's technological legacy continues to be a core component of the Siemens Healthineers diagnostics business. Its products, such as the BN series of nephelometers, remain industry standards for specific protein testing. The company played a pivotal role in advancing automated diagnostic testing in clinical laboratories worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Behring Diagnostics.